EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress

Kathryn L. White, Harshini Maheswaran, Hope Neal, Maheswaran Pitchaimuthu

Surgeries · 17.11.2026 · 7 (4) · 135

DOI: 10.3390/surgeries7040135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgeries, online erschienen am 17.11.2026. Verfasst von Kathryn L. White und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2026 American Transplant Congress, jointly organized by the American Society of Transplant Surgeons and the American Society of Transplantation, highlighted the expanding role of machine perfusion (MP) in broadening the donor pool across liver, kidney, lung, heart, and vascularized composite allograft transplantation. Of 106 relevant abstracts identified, 39 with the greatest clinical and translational relevance were selected for discussion. Across organ systems, normothermic and hypothermic MP facilitated utilization of higher-risk grafts, including donation-after-circulatory-death, steatotic, and extended-criteria organs, with early outcomes comparable or superior to static cold storage. Normothermic regional perfusion emerged as a complementary preconditioning strategy, particularly in reducing biliary complications after liver transplantation and delayed graft function after kidney transplantation. Novel biomarkers, including perfusate flavin mononucleotide, and integrated biochemical, physiologic, and histologic panels showed promise for real-time graft viability assessment. Emerging approaches, including 7-day liver preservation, ischemia-free liver transplantation, gaseous cardiac perfusion, and ex situ modeling of T-cell-mediated rejection, further suggest that MP is evolving into a therapeutic and investigative platform. Important limitations include variable benefits across recipient risk profiles, cardiac size-matching constraints, and disparities in access to normothermic liver perfusion. Multicenter validation, equitable access, and organ- and risk-specific strategies will be essential to realize the full potential of MP in transplantation.

Zitieren

APA

White, K. L., Maheswaran, H., Neal, H., & Pitchaimuthu, M. (2026). Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress. Surgeries, 7(4), 135. https://doi.org/10.3390/surgeries7040135

Vancouver

White KL, Maheswaran H, Neal H, Pitchaimuthu M. Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress. Surgeries. 2026;7(4):135. doi:10.3390/surgeries7040135

BibTeX
@article{White2026,
  author = {White, Kathryn L. and Maheswaran, Harshini and Neal, Hope and Pitchaimuthu, Maheswaran},
  title = {Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress},
  journal = {Surgeries},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {135},
  doi = {10.3390/surgeries7040135}
}
Kostenlos starten →